INTRODUCTION
Myeloid cells play numerous roles in the regulation and homeostasis of the immune system and are central players in antiviral responses. Despite being infected themselves, although to an extent related to their differentiation/activation status, circulating monocytes, resident macrophages and dendritic cells (DCs) display a strong resistance toward primate lentiviruses, a phenomenon particularly acute during the early phases of infection (1, 2) . This hostile environment is likely the result of numerous layers of restrictions that dynamically affect viral replication at multiple stages and that are only now starting to be understood from a molecular point of view. So far, only Vpx, a protein packaged into virion particles and coded by members of the HIV-2/SIV SM lineage, has been described to counter this restrictive environment, at least under certain conditions, and to exert a strong positive effect during the early phases of infection of myeloid cells with both cognate and non-cognate lentiviruses (3-7, and for a review 8). Through this viral protein, two cellular restriction factors whose antiviral activity seems mostly specific to human myeloid cells have been described so far: the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A member (APOBEC3A or A3A) and the sterile alpha motif-hydroxylase domain 1 protein (SAMHD1) (9) (10) (11) (12) (13) . More specifically, SAMHD1 has been recently shown to restrict lentiviral infection by diminishing the pool of intracellular dNTPs (14, 15) , providing a molecular explanation for previous observations indicating that myeloid cells infection was inefficient due to low dNTPs concentrations (16) (17) (18) .
Here, we characterize a large panel of Vpx mutants to determine the relationship existing between the functionality of Vpx proteins during primate lentiviral infection of primary myeloid cells and their ability to induce SAMHD1 degradation. Using the same collection of mutants, we explore the intracellular localization at which the interaction between these two proteins may occur. Our results define a number of mutations spread over the 3-helix bundle structure predicted for Vpx that impair both Vpx functionality and its ability to deplete SAMHD1 in target DCs. Certain specific mutations alter the stability of Vpx and its ability to undergo Vpx:Vpx interactions. However, no strict correlation exists between these parameters and Vpx functionality, indicating that they are not limiting factors during the early phases of infection. We define here that SAMHD1 is a nonshuttling nuclear protein that therefore accumulates in the nucleus and is unable to leave it. If WT Vpx partially colocalize with SAMHD1 in the nucleus, we identify a specific functional Vpx mutant that displays an exquisite cytoplasmic distribution and that is able to induce the partial retention of SAMHD1 in the cell cytoplasm. In light of our findings that SAMHD1 does not leave the nucleus, we believe that this mutant retains SAMHD1 in the cytoplasm before this protein enters the nucleus, probably after its translation. Overall, these results point out to an efficient and plastic manner in which Vpx counters SAMHD1.
EXPERIMENTAL PROCEDURES
Cell culture, cytokines and antibodies. 293T, HeLa and NIH3T3 cells were cultured in Dulbecco's Eagle Modified Medium (DMEM) plus 10% of fetal calf serum (FCS) and 100 U of penicillin/streptomycin. Primary blood human monocytes were purified from the blood of healthy donors obtained at the blood bank of Lyon (EFS-Lyon), as described before (7, 19) . Monocytes were differentiated into macrophages or immature dendritic cells (DCs) upon incubation for 4 to 5 days in RPMI1640 complete medium supplemented with 100 ng/ml of GM-CSF alone or in combination with IL-4 (AbCys). Anti-Flag, anti-VSVg and anti-tubulin monoclonal antibodies were purchased from SIGMA, anti-SAMHD1 antibody was purchased from AbCam and the anti-CA antibody was provided by the AIDS Reagents and Reference Program of the NIH.
DNA constructs and viral production.
A codon optimized and VSVg-epitope tagged version of SAMHD1 was synthesized and purchased by GenScript. Flag-tagged Vpx/Vpr coding plasmids were described before (20) and novel ones were generated using standard mutagenesis techniques. Nomenclature: when two identical residues are mutated within the same Vpx mutant only the identity of the first amino acid is specified (ex: K84/85A indicates that two lysines at position 84 and 85 have been mutated to alanine). HIV-1 GFP-coding lentiviral vectors were produced by co-transfection of 293T cells with 3 plasmids coding: the packaging proteins GagPro-Pol and viral non structural proteins, a mini viral genome bearing a CMV-driven eGFP reporter and the Vesicular Stomatitis Virus G envelope (VSVg) for ample cellular tropism (7). Virions were purified through a 25% sucrose cushion, resuspended and normalized by infectious titers as determined onto HeLa cells or by protein content against standards of known infectivity (exo-RT activity). Non-infectious virion-like particles (VLPs) were similarly produced using the Gag-Pol of SIV MAC , VSVg and the indicated Vpx proteins in the absence of viral genome. Virions were purified as above and normalized by exo-RT. Macrophages were similarly treated except that 24 well plates were used and infections were carried out in a final volume of 400 µl. To obtain sufficient amounts of protein for WB analysis of SAMHD1 degradation, 5x10 5 DCs were challenged with an MOI equivalent of 2 of VLPsVpx and cells were analyzed 24 hours post challenge. Transfections were carried out with calcium phosphate of HeLa, 293T or murine NIH3T3 cells, as previously described (20) .
Confocal microscopy analysis. Cells were grown on coverslips then fixed in 4% formalin (SIGMA). Free aldehydes were quenched with 50 mM NH 4 Cl-PBS and cells were then permeabilized with 0,2% or 0,5% Triton X-100 (Macrophages/DCs and HeLa/NIH3T3, respectively). After immunostaining, images were acquired using a spectral Leica sp5 or LSM 710 microscopes. Primary antibodies are described above, rhodamine-labelled Phallodin was purchased from SIGMA, while the secondary antibodies were purchased from Vector laboratories. For heterokaryons, HeLa and NIH 3T3 were cocultured on coverslips and fused at a ratio of 1:1 using PEG8000 (50%, SIGMA) in the presence of Cyclohexamide (CHX at 100µg/ml, SIGMA). Cells were analyzed by confocal microscopy 2 hours afterward. The degree of colocalization between SAMHD1 and Vpx was measured on 20 cells using the Pearson's correlation coefficient (JACoP tool: where a value of 1 indicates perfect colocalization, while a value of 0 indicates random distribution). The fraction of cytoplasmic SAMHD1 was analyzed by quantifying the Manders overlap coefficient (Fuji image software).
Pulse/Chase analysis. Transfected HeLa cells were pulsed for 30 minutes with 30 µCi of 35 S Met/Cys, prior to extensive cell washing. Cells were then chased for different time points, prior to cell lysis and immunoprecipitation, as described (21) . Vpx was immunoprecipitated using anti-Flag coated beads (SIGMA). Samples were run on an SDS-PAGE gel, prior to phosphorimager quantification.
Vpx binding assays. The ability of the different Vpx mutants to associate to WT Vpx was assessed after co-transfection of 293T cells with a GST-FLAG-WT SIV MAC Vpx construct along with FLAG-Vpx mutants prior to lysis and precipitation with gluthathione-coated agarose beads. Precipitates were then loaded on an SDS-PAGE gel and analyzed by WB.
RESULTS

The analysis of a large panel of Vpx mutants strictly correlates the functionality of Vpx during the early phases of infection of DCs with its ability to induce SAMHD1 depletion.
To identify residues of Vpx required for SAMHD1 depletion in DCs, we took advantage of a large panel of Vpx mutants that we had previously characterized with respect to their ability to be incorporated into virion particles and to increase the infectivity of HIV-1 vectors in DCs (20) . Some of these mutations had also been previously characterized for their ability to affect HIV-2 or SIV replication (22, 23) . The different mutations in Vpx span the 3 helix-bundle core predicted for this protein based on its close homology with Vpr ( Figure 1A ). Two novel mutants in conserved residues of helix 3 were added to this collection (K77A/L72A and C83R). The various Vpx mutant proteins were incorporated into non-infectious virion-like particles derived from SIV MAC (VLPs) upon cotransfection of 293T cells with an SIV MACderived Gag-Pro-Pol construct. VLPs were then harvested, normalized by protein content by exo-RT, examined for their Vpx content by WB ( Figure 1B ) and used on DCs to vehicle Vpx during infection. The ability of Vpx-VLPs to mediate an increase in HIV-1 infectivity was assessed by flow cytometry 3 days after infection, while their ability to deplete SAMHD1 in target DCs was assessed by WB. In line with what we had previously reported, all the Vpx mutants were readily incorporated into VLPs upon co-transfection with Gag-Pol expression plasmids, although 3 mutants displayed lower incorporation rates (ΔPro, Y66A/69A/71A and W49A/53A/56A, Figure 1B ). Then, exo-RT normalized Vpx-VLPs were provided in trans during the infection of DCs with a constant amount of GFP-coding HIV-1 LVs and their effect on infectivity measured by flow cytometry 3 days afterwards ( Figure 1C ). As we and others have previously reported (20) , a number of mutations in Vpx affect its ability to relieve the restrictive phenotype of DCs to incoming HIV-1 particles (S13A/T17A/28A, K68/77A, Y66A/69A/71A, W49A/53A/56A and Q76A). Of the novel mutants tested here, one was functional, while the second was not (C83R and K77A/L72A, respectively). Next, the ability of these mutants to degrade endogenous SAMHD1 during the early phases of infection of DCs was assessed by WB ( Figure 1D ). All non-functional Vpx mutants were unable to deplete SAMHD1 in DCs (S13A/T17A/28A, K77A/L72A, K68/77A, Y66A/69A/71A and the W49A/53A/56A, while Q76A only modestly and non-reproductively affected SAMHD1 levels). On the contrary, all functional mutants did degrade SAMHD1 in DCs. In the case of the Y66A/69A/71A and W49A/53A/56A Vpx mutants, the impairment in inducing SAMHD1 depletion cannot be ascribed to their lower incorporation into VLPs, because the ΔPro Vpx mutant is incorporated to similar levels, yet it is able to induce SAMHD1 degradation.
SAMHD1 is degraded rapidly and does not leave the nucleus during infection.
The intracellular localization of SAMHD1 during infection remains unclear, as published data support either a nuclear or a cytoplasmic relocalization (24) (25) (26) . In the absence of infection, endogenous SAMHD1 presented an exclusively nuclear staining in both primary macrophages and DCs, and an identical localization was observed upon ectopic expression in HeLa cells and in murine NIH3T3 (Figure 2A ), confirming the described nuclear localization of SAMHD1 under normal conditions. To determine whether SAMHD1 relocalized during infection, primary macrophages, that also display a Vpx-dependent phenotype but that by their tight adherence and spread cytoplasm proved more amenable than DCs for extensive confocal microscopy studies, were challenged with equal amounts of HIV-1 or SIV MAC vectors containing or devoid of Vpx (at a multiplicity of infection, MOI, of 2). Cells were then examined at different time points after infection to determine the presence and the localization of SAMHD1 ( Figure 2B displays representative cells over 400 scored per virus/time point/experiment and for space constraints only results obtained up to 150 minutes with SIV MAC vectors are presented). Under these conditions, degradation of SAMHD1 occurred rapidly in the presence of Vpx and the protein virtually disappeared by 12 hours post infection (t 50% value ≅1,45hrs, Figure 2C ). These values are more rapid than those reported previously upon WB analysis, but we believe these differences are solely due to the distinct techniques used (15) . On the contrary, SAMHD1 was clearly detected when macrophages where challenged with an SIV MAC virus devoid of Vpx or with HIV-1 (not shown here). Of note, the Vpx protein present in incoming viral particles could not be reliably detected in transduced cells, most likely because of amounts that are below the levels of detection of the assay.
At no time point during infection with any of the viruses used here, SAMHD1 was observed outside the nucleus, indicating that this protein does not leave this location during viral infection ( Figure 2B for representative pictures).
Overall, these results indicate very rapid kinetics of degradation of SAMHD1, in agreement with the kinetics of the early phases of infection that we and others have measured in myeloid cells (27) .
SAMHD1 is a prototypical non-shuttling nuclear protein.
The results presented above strongly suggest that SAMHD1 may be a nuclear non-shuttling protein that is therefore unable to exit the nucleus once this destination is reached. To formally prove it, we assessed whether SAMHD1 possessed the intrinsic ability to shuttle from a donor nucleus (HeLa) to a recipient one (3T3) upon PEG-induced fusion of these two cell types in heterokaryons (according to the scheme of Figure 3A ). Cells were then examined by confocal microscopy and true heterokaryons were identified through phalloidinmediated actin staining ( Figure 3B and 3C, depicting representative pictures of over 80 heterokaryons scored per condition). This technique relies on the clear difference in DAPI pattern between murine and human species nuclei and has been largely used to define the shuttling properties of nuclear proteins (28, 29) . As a positive control, the nuclear shuttling EpsteinBarr virus EB2 protein was used (30) . When heterokaryons were thus examined, SAMHD1 was never found in recipient 3T3 nuclei, contrarily to EB2. Since SAMHD1 displays a nuclear staining when ectopically expressed in murine 3T3 (see Figure 2A) , this inability cannot be ascribed to species-specific differences in nuclear entry pathways. Therefore, our results define SAMHD1 as a typical non-shuttling by guest on June 19, 2017 http://www.jbc.org/ Downloaded from nuclear protein that accumulates in the nucleus, but is unable to leave it.
A functional Vpx mutant induces the accumulation of SAMHD1 in the cell cytoplasm. Since SAMHD1 is a nuclear protein and WT Vpx displays a composite intracellular distribution, in both nucleus and cytoplasm (20) , WT Vpx is likely to interact with SAMHD1 directly in the nucleus, as proposed (24, 26) . However, we have previously reported that the functional K84A/85A Vpx mutant displays a strict cytoplasmic distribution (20) , so that a direct interaction between these two proteins in the nucleus is unlikely. To determine whether this mutant affected the localization of SAMHD1, both proteins were ectopically expressed in HeLa cells then examined by confocal microscopy ( Figure 4 ). While WT Vpx displayed a diffused staining that co-localized with SAMHD1 in the nucleus, the K84A/K85A Vpx mutant induced the accumulation of, and partially co-localized with, SAMHD1 in a clear punctate pattern in the cell cytoplasm. SAMHD1 and Vpx displayed elevated colocalization in the cytoplasm (Pearson coefficient of 0,96) and involved up to 5,2%+ 1,3% of the total SAMHD1 signal. Given that SAMHD1 does not leave the nucleus once it reaches it, and that the K84A/85A Vpx mutant resides in the cytoplasm, these results indicate that the K84A/85A Vpx mutant likely intercepts a fraction of SAMHD1, before it enters the nucleus.
The KK84/85A Vpx mutant displays no kinetic defects over WT and induces an MG132-dependent degradation of SAMHD1.
To determine whether functional differences existed between nuclear and cytoplasmic interactions, we determined whether the KK84/85A Vpx mutant exhibited kinetic differences in the degradation of SAMHD1 by comparing it to WT Vpx. To this end, primary macrophages were challenged as above with SIV MAC -derived VLPs incorporating either WT or mutated Vpx and the percentage of SAMHD1+ cells was scored over time ( Figure 5A , for a cumulative analysis and 5B for representative cells over more than 400 scored per virus/condition/experiment).
Under these conditions, no differences were observed in the kinetics of SAMHD1 degradation between WT and KK84/85A Vpx mutant, indicating that both were able to induce the rapid and efficient degradation of SAMHD1. The addition of the proteasome inhibitor MG132 during infection prevented SAMHD1 degradation in both cases, indicating that both Vpx proteins depleted SAMHD1 in a proteasome-dependent manner.
The ability to degrade SAMHD1 is largely independent from the stability of Vpx. Contrarily to the pool of SAMHD1 that is supposed to be constantly renewed in the cell through protein translation, only a given amount of Vpx is present during the early phases of infection (the one present in incoming virion particles). Thus, it is possible that the efficiency with which SAMHD1 is degraded is influenced by the stability of Vpx. To determine whether this was the case, we measured the half-life of several Vpx mutants by 35 S Met/Cys metabolic labeling and immunoprecipitation in transfected HeLa cells. In agreement with a previous study (31) , WT Vpx displays a t 50% value of 30hrs +/-2 hrs (Panel of Figure 6A for an example and graph for a compilation of independent experiments over a longer time frame). The stability of the different Vpx mutants was then analyzed at 24hrs post labeling with respect to the amount of protein labeled at t0 ( Figure 6B ). Under these conditions, WT HIV-2 and SIV MAC Vpx displayed similar stabilities, while the distantly related, and non-functional, SIV RCM Vpx was highly unstable (8-fold less protein remaining at this time point compared to WT). Several mutants displayed wild type stability (S13A, S13A/T17A/28A, S52A, Y66A/69A/71A, K84/85A and Q76A), two mutants displayed only a slight decrease in their stability (W49A/53A/56A, C83A, 1,8 and 2,5 fold lower than WT), while two were more drastically reduced (K77A/72A and ΔPro, 5,6 and 5,7 fold). As at least two mutants with reduced stability exhibited WT functionality (C83A and ΔPro), these results indicate that Vpx stability is not a limiting factor in the degradation of SAMHD1, at least within the variations that we have measured in the mutants described here.
The decreased stability of Vpx may relate to a decreased ability to undergo Vpx:Vpx interactions. To determine whether the Vpx mutations affected Vpx:Vpx interactions, a set of Vpx mutants was assayed for its ability to associate to WT-Vpx-GST upon coexpression in 293T cells ( Figure 6C ). WT SIV MAC and HIV-2 Vpx proteins, but not the distantly related SIV RCM , associated to WT-Vpx-GST, as most of the mutants examined here. The sole exceptions were the mutant Q76A that bound to a lower extent and the ΔPro and K77A/L72K mutants that had lost their ability to associate to WT-Vpx-GST. As shown above, the latter two Vpx mutants displayed decreased stability over wild type, indicating that the ability to undergo Vpx:Vpx interactions may stabilize Vpx. However, this property does not seem to be associated to the functionality of Vpx mutants during the early phases of infection of DCs. DISCUSSION SAMHD1 has been recently identified as a prominent factor counteracted by Vpx, and to better characterize this interaction, we have reexamined a large panel of Vpx mutants that we had previously characterized for their ability to increase lentiviral infectivity in DCs. Our results indicate that a strict correlation exists between the functionality of Vpx in DCs infection and its ability to mediate SAMHD1 depletion, pointing to the fact that the removal of this factor is a key event for the efficient lentiviral infection of these cells. Our analysis identifies several residues distributed throughout Vpx that are important for this function. Some of them have been reported, albeit controversially, to be sites of post translational modification of Vpx, as phosporylation (23,32). These modifications may finely regulate the ability of Vpx to interact with SAMHD1 and with other cellular factors that concur in the restrictive environment of myeloid cells against lentiviruses, an hypothesis that we are currently exploring. Given that only a definite amount of Vpx is present during the early phases of infection (the one incorporated into virions), we assessed whether Vpx protein stability could ultimately affect its functionality. Our results indicate that Vpx stability is not a determining factor in Vpx functionality, as at least two Vpx mutants with decreased stability retain wild type functionality during the infection of DCs (C83R and ΔPro). Similarly, the ability to undergo Vpx:Vpx interactions does not seem a major factor in the functionality of Vpx, as two Vpx mutants fail to associate to WT Vpx, yet behave as wild type (K77A/L72A and ΔPro). Thus, although the stability of Vpx seems to be influenced by Vpx:Vpx interactions, neither parameters are limiting in the functionality of Vpx, suggesting that Vpx may remove SAMHD1 as a monomer and in an highly efficient manner, through the Cul4A-DDB1-DCAF1 E3 ubiquitin ligase complex, (3, 4, 33, 34) , although a DCAF1-independent mechanism of action of Vpx has been also proposed (20, 35) . The intracellular localization in which SAMHD1 and Vpx interact during infection remains unclear. The localization of Vpx does not seem to be a limiting factor, given that Vpx exhibits both nuclear and cytoplasmic distributions. In contrast, the localization of SAMHD1 in the presence or absence of viral challenge is less clear. If most reports indicate SAMHD1 as essentially nuclear (24, 26, 36, 37) , a recent study indicated that SAMHD1 could be also found in the cytoplasm, at least in quiescent lymphocytes (38) . Similarly, SAMHD1 degradation had been suggested to occur entirely in the nucleus based on the observations that NLS mutants of SAMHD1 (ie cytoplasmic) could resist Vpx-mediated degradation (24, 26) . However, this is in contrast with the fact that Vpx removes both nuclear and cytoplasmic fractions of SAMHD1 during the infection of quiescent lymphocytes. Lastly, Vpx has been proposed to induce the relocalization of SAMHD1 in the cell cytoplasm (25). Our analysis of the intracellular distribution of SAMHD1 in primary macrophages during viral infection indicates that endogenous SAMHD1 does not relocalize in the cell cytoplasm during infection. This observation is supported by heterokaryon experiments that indicate that SAMHD1 does not possess a nuclear export signal and that therefore once it enters the nucleus, lacks the ability to leave it. Given that Vpx reaches the nucleus, the simplest explanation is that WT Vpx degrades SAMHD1 directly in this location as proposed (24, 26) . However, the functionality of a Vpx mutant that displays an exquisite cytoplasmic distribution suggests a more complex and perhaps dynamic mechanism of degradation. Before reaching its final destination in the nucleus, SAMHD1 has to transit through the cell cytoplasm after its translation. The results obtained with our K84/85A Vpx mutant suggest that during this time SAMHD1 is also targeted for degradation by Vpx. Since WT Vpx is also distributed in the cell cytoplasm, this mechanism of degradation may therefore apply also to WT Vpx. The fact that these cytoplasmic foci of SAMHD1 and Vpx are detectable only upon co-expression with the K84A/K85A and not WT Vpx may indicate that the mutant is more efficient at retaining SAMHD1 in the cytoplasm, so that its accumulation becomes detectable only in this case with the technique used here.
This mechanism of cytoplasmic degradation is highly efficient as no kinetic differences were observed in primary macrophages between mutant and WT Vpx protein and in both cases, degradation proceeded through a proteasomedependent mechanism, as attested by the impairment of SAMHD1 degradation in the presence of MG132. Thus, while the nuclear pool of SAMHD1 is depleted directly in the nucleus, Vpx may also intercept newly generated SAMHD1 before it enters the nucleus, exerting the very potent degradation activity that is observed here.
Finally, the restrictive environment of myeloid cells is likely the result of several mechanisms of defense to which numerous cellular factors and among them SAMHD1, contribute more or less effectively. Multiple lines of evidence clearly indicate the presence of additional factors that are not counteracted by Vpx, as demonstrated by the drastic drop in infectivity observed upon stimulation of DCs with interferons in viruses naturally coding Vpx (HIV-2/SIV SM members) (35) . Whether and how these restrictions are connected to the basal mechanism of resistance specified by SAMHD1 remains to be determined. 
